STOCK TITAN

Aveanna Healthcare Holdings, Inc. Stock Price, News & Analysis

AVAH Nasdaq

Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is described as a diversified home care platform focused on medically complex, high-cost patient populations, with headquarters in Atlanta, Georgia and locations in 38 states. The AVAH news page on Stock Titan aggregates company press releases and market updates that explain how Aveanna delivers pediatric and adult nursing, therapy, home health, hospice, and medical product services in home and community settings.

Visitors to this page can review Aveanna’s own announcements on topics such as updated full year financial guidance, preliminary and final quarterly results, and commentary on non-GAAP measures like EBITDA, Adjusted EBITDA, and Normalized Adjusted EBITDA. News items also cover participation in healthcare and finance conferences, including events hosted by financial institutions, where the company’s management presents to investors and holds one-on-one meetings.

Other Aveanna releases describe capital markets activity and financing developments, such as secondary offerings of common stock by existing stockholders and amendments to credit facilities and term loans. These updates provide context on the company’s capital structure, refinancing transactions, and relationships with lenders and underwriters.

Because Aveanna positions its services as a high quality, lower cost alternative to prolonged hospitalization, news about its financial performance, strategic financing actions, and investor presentations can be relevant to those tracking trends in home-based care for medically fragile and chronically ill children and adults. For ongoing coverage of AVAH, investors and observers can use this page to follow the company’s reported milestones, regulatory disclosures referenced in press releases, and other public communications.

Rhea-AI Summary

Aveanna Healthcare (Nasdaq: AVAH) has successfully completed a significant debt refinancing transaction. The company has refinanced its $886.0 million first lien term loans and secured $439.0 million in incremental first lien term loans, bringing the total to $1.325 billion with extended maturity to 2032.

Additionally, AVAH increased its revolving credit facility from $170.3 million to $250.0 million, extending its maturity to 2030. The company used the proceeds to fully repay its $415.0 million second lien term loans. Barclays Bank PLC and Jeffries Finance LLC acted as co-lead arrangers for the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.7%
Tags
none
-
Rhea-AI Summary

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its participation in the upcoming Jefferies Healthcare Services Conference in Nashville on September 30, 2025. The company's management team will engage in one-on-one investor meetings and conduct a fireside chat at 3:00 PM Central Time.

Investors can access the fireside chat through a live webcast on Aveanna's Investor Relations website at ir.aveanna.com. A replay will be available for a limited time after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its management team's participation in the upcoming Deutsche Bank Healthcare Summit in New York on September 10, 2025. During the event, the management will conduct one-on-one meetings with investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.27%
Tags
conferences
Rhea-AI Summary

Aveanna Healthcare Holdings (NASDAQ: AVAH), a leading home care platform, reported strong Q2 2025 financial results with significant growth across all divisions. Revenue increased 16.8% to $589.6 million, while net income surged 94.3% to $27.0 million. Adjusted EBITDA grew 93.6% to $88.4 million.

The company raised its full-year 2025 guidance, projecting revenue of over $2.3 billion (up from $2.15 billion) and Adjusted EBITDA of over $270 million (up from $207 million). The quarter was marked by the strategic acquisition of Thrive Skilled Pediatric Care, expanding Aveanna's market presence and core services.

As of June 28, 2025, Aveanna maintained a strong liquidity position with $100.7 million in cash and total available borrowing capacity of $253.3 million across its facilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
49.36%
Tags
-
Rhea-AI Summary

Aveanna Healthcare (NASDAQ: AVAH) has scheduled its second quarter 2025 earnings release and conference call. The company will release results before market open on Thursday, August 7, 2025, followed by a conference call at 10:00 a.m. ET.

Investors can access the call via phone (1-877-407-0789 for US, 1-201-689-8562 for international) or webcast through the company's investor relations website. A replay will be available for one week with passcode 13754011.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
conferences earnings
-
Rhea-AI Summary
Aveanna Healthcare Holdings (NASDAQ: AVAH) has completed the acquisition of Thrive Skilled Pediatric Care (Thrive SPC), a major independent pediatric home care provider operating across 23 locations in seven states. Thrive SPC specializes in Private Duty Nursing services, along with Pediatric Therapy, Licensed Health Aide Services, and Certified Nurse Assistant Services. The strategic acquisition expands Aveanna's presence in existing markets while entering two new states. The transaction was financed through a combination of common stock shares and cash. CEO Jeff Shaner emphasized the acquisition's alignment with Aveanna's mission of delivering high-quality care and clinical innovation. Edge Healthcare Partners and Bass, Berry & Sims served as Aveanna's advisors, while Cantor Fitzgerald & Co. and Ropes & Gray LLP represented Thrive SPC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.53%
Tags
Rhea-AI Summary
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q1 2025 financial results, with revenue increasing 14.0% to $559.2 million compared to Q1 2024. The company achieved significant improvements in profitability, posting a net income of $5.2 million versus a net loss of $11.2 million in the prior year period. Adjusted EBITDA surged 93.1% to $67.4 million. Based on this strong performance, Aveanna revised its 2025 guidance upward, now expecting revenue greater than $2.15 billion and Adjusted EBITDA exceeding $207 million. The company's growth was driven by strategic cost reductions, successful preferred payor strategy, and improved reimbursement rates. As of March 29, 2025, Aveanna maintained a solid liquidity position with $71.5 million in cash and significant borrowing capacity through various facilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.11%
Tags
-
Rhea-AI Summary

Aveanna Healthcare (NASDAQ: AVAH) has announced its participation in the upcoming RBC 2025 Global Healthcare Conference in New York on May 20, 2025. The company's management team will engage in two key activities during the event:

  • One-on-one meetings with investors
  • A fireside chat scheduled for 11:30 a.m. Eastern Time

Interested parties can access a live webcast of the presentation through Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a limited time following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
conferences
-
Rhea-AI Summary

Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. The company's management team will engage in two key activities:

1. Host one-on-one investor meetings

2. Deliver a presentation at 3:15 PM Pacific Time

Investors and interested parties can access the presentation through a live webcast on Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a time after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.55%
Tags
conferences
Rhea-AI Summary

Aveanna Healthcare Holdings (NASDAQ: AVAH) has scheduled its first quarter 2025 earnings release and conference call. The company will announce Q1 results before market open on Thursday, May 8, 2025, followed by a conference call at 10:00 a.m. Eastern Time.

Investors can access the call via phone (1-877-407-0789 for domestic, 1-201-689-8562 for international) or webcast through the company's Investor Relations website. A replay will be available for one week online and until May 15 via phone (1-844-512-2921 domestic, 1-412-317-6671 international) using passcode 13752435.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
conferences earnings

FAQ

What is the current stock price of Aveanna Healthcare Holdings (AVAH)?

The current stock price of Aveanna Healthcare Holdings (AVAH) is $7.93 as of February 15, 2026.

What is the market cap of Aveanna Healthcare Holdings (AVAH)?

The market cap of Aveanna Healthcare Holdings (AVAH) is approximately 1.7B.

AVAH Rankings

AVAH Stock Data

1.66B
26.44M
Medical Care Facilities
Services-home Health Care Services
Link
United States
ATLANTA

AVAH RSS Feed